Mary Elkins
- Infectious Diseases top 0.2%
- Epidemiology top 1%
- Virology top 0.2%
- General Health Professions top 1%
- Emergency Medicine top 0.5%
- Co-authors
- Richard D. GelberPamela StrattonEdward H. O'NeillMary Jo O’SullivanRhoda SperlingWilliam T. ShearerEdward M. ConnorJack Moye
- Topics
- HIV/AIDS drug development and treatment (7 papers)HIV Research and Treatment (6 papers)HIV/AIDS Research and Interventions (4 papers)
- Journals
- New England Journal of MedicineThe Journal of Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesCameroonFrance
In The Last Decade
Mary Elkins
9 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 3.5k
- Epidemiology 1.8k
- Virology 1.6k
- General Health Professions 886
- Emergency Medicine 662
Countries citing papers authored by Mary Elkins
This map shows the geographic impact of Mary Elkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Elkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Elkins more than expected).
Fields of papers citing papers by Mary Elkins
This network shows the impact of papers produced by Mary Elkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Elkins. The network helps show where Mary Elkins may publish in the future.
Co-authorship network of co-authors of Mary Elkins
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Elkins. A scholar is included among the top collaborators of Mary Elkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Elkins. Mary Elkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 42 | |
| 3 | 26 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatmentbreakdown → | 1387 |
| 7 | Inter-Company Collaboration Combination Trials. Clinical Trial Subcommittee of the Inter-Company Collaboration for AIDS Drug Development. | 2 |
| 8 | Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatmentbreakdown → | 2509 |
| 9 | 91 |
About Mary Elkins
Mary Elkins is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 9 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (3.5k citations) and Emergency Medicine (662 citations). Mary Elkins has collaborated with scholars based in United States, Cameroon and France. Frequent co-authors include Richard D. Gelber, Pamela Stratton, Edward H. O'Neill, Mary Jo O’Sullivan, Rhoda Sperling, William T. Shearer, Edward M. Connor, Jack Moye, Mary Culnane and Gwendolyn B. Scott. Their work appears in journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.